• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Merck & Co.

edit

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com

Milestones

edit

• 
  Merck & Co. added Peter Wendell as Board of Directors.
  Posted 7/18/11 at 8:00am
• 
  Merck & Co. added Paula Cristina Machado as Multi-channel Marketing Communications Manager.
  Posted 6/10/09 at 1:35am
• 
  Went public with stock symbol NYSE:MRK.
  Posted 7/21/10 at 7:08pm
• 
  Merck & Co. acquired Inspire Pharmaceuticals for $430M. (4/5/11)
  Posted 4/5/11 at 11:06pm via merck.com
• 
  Merck & Co. acquired SmartCells for $500M. (12/3/10)
  Posted 12/7/10 at 7:47pm via dowjones.com
• 
  Merck & Co. — SmartCells Inc., a Beverly diabetes drug developer, is to be acquired by Merck & Co. Inc. for a total of about $500 million (12/2/10)
  Posted 12/2/10 at 8:24am via masshightech.com
• 
  Merck & Co. — Merck buys vax unit from bankrupt Hawaii Biotech (7/21/10)
  Posted 7/21/10 at 7:16pm via fiercebiotech.com

Videos

Screenshots

edit

Stock Price

Sources

1. Merck to Acquire Inspire Pharmaceuticals, Inc. (merck.com) [edit]
2. Angel Backing Lifted SmartCells To $500M Merck Acquisition (fis.dowjones.com) [edit]
3. Merck buys vax unit from bankrupt Hawaii Biotech (fiercebiotech.com) [edit]
4. Merck acquires diabetes drug firm SmartCells (masshightech.com) [edit]